Clinical trials: Schistosoma Mansoni

Schistosomiasis

L-PZQ ODT in Schistosoma Infected Children

• Completed
• Age: 3 months to 6 years
• Phase 3
• Results posted

The study would evaluate the safety and efficacy of L-praziquantel orodispersible (L-PZQ ODT) tablets in Schistosoma infected children aged 3 months to 6 years.

Trial name

NCT03845140

Testing

L-PZQ ODT 50 mg/kg, Biltricide®, L-PZQ ODT 60 mg/kg

Where

2 sites in Côte d’Ivoire, Kenya

Volunteers

288 people

Sponsor

Merck KGaA, Darmstadt, Germany